Daily Stock List
Global Clean Energy, Inc. (GCEI)
USA Market News, AimHighProfits, Research Driven Investor, Stockdigest report, Michael Stone, Research Driven Alerts, and PickPennyStocks reported this month on Global Clean Energy, Inc. (GCEI), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Global Clean Energy, Inc. is a waste-to-energy conversion solutions company. They are concentrating their efforts on utilizing available and developing technologies to convert waste into commercially viable energy. The Company refers to this process as Reforming Environmental Salvage into Clean Usable Energy (R.E.S.C.U.E.). Global Clean Energy develops mid-size biomass and waste-to-energy and biofuels projects that can be funded based on long-term feedstock supply and energy off-take agreements. Global Clean Energy lists on the OTC Pink Current Information. The Company has their corporate headquarters in Humble, Texas.
Global Clean Energy serves governments, such as municipalities, as well as industries, including food, paper, and chemical products that require process heat and electric power. The R.E.S.C.U.E process recovers and reforms environmental salvage into clean useable energy in Canada and North America. Global Clean Energy has developed proprietary technologies to focus on two specific niches of the Green Alternative Energy Sector, (GAES). One is the conversion of slurry pond residues to dry slurry via their proprietary "Cyclone Dredging" technology. The second is the construction of specialized gasification plants, using their gasification/pyrolytic steam reforming technology (Gasification/PSR Technology) to convert the carbon based feedstock into clean usable energy.
At the beginning of October, the Company announced that they continue to develop their plan to provide the most efficient feedstocks for biomass fuel production. They have started to provide for production of Jatropha and switch grass in rural America. The third most efficient feedstock for conversion into biofuel is algae. Their proposed algae production locations are in rural America, where job creation is a priority. The Company has targeted the Rio Grande Valley of Texas to start their algae production. Global Clean Energy is attempting to acquire abandoned shrimp farms with infrastructure in place, to produce algae, consequently limiting additional capital investments.
Last week, Global Clean Energy announced that they initiated their first round of funding negotiations with three lenders. Earl Azimov, President/CEO, is leading the effort. The goal is to do a combination of asset based lending and a line of credit. The total funding objective is twenty million dollars over the next eighteen months. The funding will provide the necessary capital to complete the acquisition of Houston Industrial Materials and begin the work on construction of the Company's gasification unit.
The grants division of Global Clean Energy filed applications for grants totaling $8.7 million to seek demonstration projects on their Jatropha and landfill system in the southern United States. They are in the final process of applying for grants for the utilization of their vortex pumping system to bring methane hydrates safely to containment. Global Clean Energy is preparing presentations for specific universities to form strategic alliances that will involve research in the renewable energy applications in the Company's business plan.
Global Clean Energy, Inc. (GCEI), closed Friday’s session at $0.0540, even for the day, on 106,869 volume with 17 trades. The average volume for the last 60 days is 274,379 and the stock's 52-week low/high is $0.001/$0.159.
Hemp, Inc. (HEMP)
Penny Stock Rumble and Bull in Advantage reported this week on Hemp, Inc. (HEMP), Nebula Stocks did previously, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Hemp, Inc. focuses on the immense market created by the fast emerging, and growing, multibillion-dollar industrial hemp industry. The Company does not involve in the cultivation or marketing of medical marijuana. Hemp is building infrastructure with the potential to gain significant market share before and after industrial hemp prohibition ends. This is pending any federal licensing or other requirements, which may be enacted after hemp prohibition ends. Hemp lists on the OTC Pink Current Information.
The Company believes in "upstreaming" a portion of profit from the marketing of their finished hemp goods back to their originator. In most cases, this will be the American farmer, cultivating natural, sustainable products. The CEO of Hemp, Mr. Bruce Perlowin, is positioning the Company as a leader in the industrial hemp industry, with a social and environmental mission at their core.
Hemp has partnered with Hemp.com, the premier domain name in the industry. With a long history as a URL and a solid foundation, the Company believes that Hemp.com provides the vehicle to drive industrial hemp back to the homes of consumers across the United States and worldwide. Hemp.com has top quality researchers, writers, editors and a professional technical staff.
Hemp.com's mission is to become the premier site for all things hemp. They will provide the community a digital stage to share information and products. The soon to be launched Hemp.com Marketplace will allow artisans to display their wares. The centralized Hemp Store will make it easier for consumers to spend their dollars, as they like, on hemp-based products.
Hemp is the manufacturer of the all-natural HerbaGenix™ line that contains hemp extracts. Earlier this month, Hemp announced that the Company agreed on collaborating with the international magazine, The Art of Mary Jane, currently in over 10 countries and expanding. The mass exposure of the HerbaGenix™ hemp nutraceuticals, specifically Mary Jane Lover (MJ Lover) will inevitably put MJ Lover in retail outlets in all 50 states and give it distribution in global markets.
MJ Lover, a product of Hemp's HerbaGenix™ product line is derived from a blend of organic nutrients, herbs, and vitamins including hemp extract (0.00 percent THC) and AFA blue-green algae, known for its healthful effects. The product is cGMP compliant to FDA standards; it is scientifically proven to promote health and give a natural energy boost.
Hemp, Inc. (HEMP), closed Friday’s session at $0.058, up 45.00%, on 6,649,078 volume with 380 trades. The average volume for the last 60 days is 579,385 and the stock's 52-week low/high is $0.01/$0.05.
IsoRay, Inc. (ISR)
Barchart and SmarTrend Newsletters reported this week on IsoRay, Inc. (ISR), Streetwise Reports, Coattail Investor, Investment House, All about trends did earlier, and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
IsoRay, Inc. is a medical technology company and innovator in seed brachytherapy and medical radioisotope applications. The Company, through their subsidiary, IsoRay Medical, Inc., is the exclusive producer of Cesium-131 internal radiation therapy, which is expanding brachytherapy options throughout the body. IsoRay utilizes proprietary technologies to deliver novel brachytherapy approaches to clinicians. Their Cesium-131 isotope has been used as a primary treatment for prostate cancer in more than 7,000 patients. IsoRay is based in Richland, Washington.
The Company was established in 1998 to develop, manufacture and market isotopes for use in the medical treatment of a variety of malignant diseases. The Company's founders included recognized experts in the medical isotope field, including Lane A. Bray, Chief Chemist of IsoRay Medical™, who developed the patented process for economically separating and purifying Cesium-131. During the 2012 fiscal year, the Barrow Neurological Institute performed the first meningioma brain tumor cases utilizing IsoRay's Cesium-131 seed mesh.
The Cesium-131 Brachytherapy Seeds and IsoRay's GliaSite® balloon catheter offers physicians and their patients another option using an innovative new choice in isotope for the treatment of a number of cancers through combining Cs-131's significantly shorter half-life with a high level of energy. During the 2012 fiscal year, IsoRay obtained Food and Drug Administration (FDA) clearance for their GliaSite® Radiation Therapy System. The GliaSite® Radiation Therapy System was used on IsoRay's first patient in December of 2011. IsoRay received their CE Mark certification for the GliaSite® Radiation Therapy System, allowing marketing in 31 European countries.
In late September, IsoRay announced their financial results for the quarter and year ended June 30, 2012. In fiscal year 2012, the Company achieved significant progress in their strategic refocus on non-prostate cancer treatments. These increased 75 percent from the year before to account for approximately 14 percent of total sales. Overall, sales declined slightly to $5,021,088 because of a weak prostate treatment market.
In the fourth quarter, revenues grew 4.4 percent with non-prostate revenues increasing 174 percent in the fourth quarter 2012, in comparison to the fourth quarter 2011. Sales came from the treatment of brain cancer, lung cancer, gynecological cancer, and head and neck cancer using Cesium-131 and from sales of the GliaSite® Radiation Therapy System, used to treat brain cancer.
IsoRay, Inc. (ISR), closed Friday’s session at $0.6961, up 2.37% on 82,613 volume with 130 trades. The average volume for the last 60 days is 271,411 and the stock's 52-week low/high is $0.3821/$1.60.
Ridgeline Energy Services, Inc. (RLE.V)
Today we are reporting on Ridgeline Energy Services, Inc. (RLE.V), here at the QualityStocks Daily Newsletter.
Ridgeline Energy Services, Inc. is an energy services and water treatment technology company. They are applying proprietary technology to treat water generated from industrial and commercial wastewater markets. These markets include a broad spectrum of clients across a wide array of industries including oil and gas. Ridgeline has a 10 plus year history providing environmental services to the oil and gas industry in North America.
By way of their environmental consulting and remediation divisions, Ridgeline Environment has built a reputation as an established provider of environmental services to the Western Canadian oil and gas industry. Ridgeline GreenFill provides soil remediation and wet waste disposal services to the oil and gas industry. Ridgeline has offices located in Red Deer, Edmonton, Grande Prairie, and Lethbridge, Alberta; Lloydminster, Saskatchewan; Vancouver, British Columbia; Phoenix, Arizona; and Los Angeles, California. The Company's shares trade on the TSX Venture Exchange.
In late September, Ridgeline Energy Services announced that the Company exercised their option to purchase the Santa Fe Springs property. The Santa Fe Springs property is a 17-acre parcel of industrially zoned real estate centrally located in the Los Angeles basin. The Lease and Option to Purchase Agreement (LOPA) with Lakeland Development Co. (Lakeland) was previously announced in April 2012, along with the execution of an Asset Purchase Agreement (APA). The expectation is that Ridgeline will close the LOPA concurrent with the closing of the APA. The Company has been operating and conducting business under a lease and a management agreement at Santa Fe Springs since April 2012.
The location of the site, together with the existing water discharge permit, has allowed Ridgeline to construct a multi-million dollar production facility using their proprietary water treatment technology. Currently, the Company has one operating water treatment installation in operation and a second system ready to begin treatment. Three more systems are in various stages of construction. Ridgeline plans eight to nine systems to undergo installation on their Santa Fe Springs property over the next 6-9 months.
In early October, Ridgeline announced that effective October 3, 2012, they closed the previously announced (October 1, 2012) transaction to acquire the assets of Piedmont Technical Services, Inc. (PTEC). PTEC is a private equipment manufacturing company headquartered in Charlotte, North Carolina. They specialize in the production, sale and leasing of dissolved air systems. These systems assist in the treatment of wastewater by removing suspended matter, including oils and solids.
Yesterday, Ridgeline Energy Services announced that they appointed (effective October 11, 2012) Mr. Dennis M. Danzik to the Board as an Executive Director subject to TSX-V approval. Mr. Danzik is an engineer by profession. He is also the inventor, and developer of Ridgeline's water treatment systems. Mr. Danzik is a noted and published expert in polyolefin design and application, and a retired U.S. defense contractor.
Ridgeline Energy Services, Inc. (RLE.V), closed Friday’s session at $0.51, up 2.00%, on 90,400 volume. The stock's 52-week low/high is $0.49/$1.41.
U.S. Geothermal, Inc. (HTM)
UndiscoveredEquities reported last week on U.S. Geothermal, Inc. (HTM), ChartPoppers, PennyStockVille, PennyInvest, StockRich, MadPennyStocks, StockEgg, BullRally, CoolPennyStocks, HotOTC did earlier, and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
U.S. Geothermal, Inc. is a leading renewable energy development company headquartered in Boise, Idaho. The Company develops geothermal energy resources for electrical power and direct uses. U.S. Geothermal is operating geothermal power projects at Raft River, Idaho and San Emidio, Nevada. The Neal Hot Springs project in eastern Oregon is presently under construction. It will be the Company's third operating power project. Neal Hot Springs is in Malheur County, Oregon and has been established as a commercial geothermal resource. An independent reservoir certificate was received for Neal Hot Springs during the year ended March 31, 2012. Construction activities advanced significantly at Neal Hot Springs and San Emidio.
U.S. Geothermal holds geothermal energy rights to 69,500 acres consisting of six advanced stage geothermal development projects. Their Raft River geothermal project is in southern Idaho, approximately 200 miles SE of Boise, at the site of a former U.S. Department of Energy geothermal installation. The Company currently owns and/or leases approximately 8.2 square miles of land with a proven geothermal reservoir that may be capable of producing up to 110 megawatts of power based on estimates from GeothermEx, Inc.
US Geothermal acquired the project in 2002. Construction of a 13MW net capacity power plant commenced in June 2006. The Company achieved commercial power generation on January 3, 2008. Idaho Power Company is purchasing the power under the terms of a 25-year PPA.
Concerning San Emidio, the San Emidio expansion is planned to take place in three phases. Phase I is a repower, and Phases II and III are planned to be expansions. Phase I utilizes the existing production and injection wells with installation of a new, more efficient 8.6 MW net power plant which achieved commercial operation on May 25, 2012. Phase II is a planned expansion within the bounds of the existing San Emidio geothermal reservoir. It is subject to the successful development of additional production wells via exploration and drilling activities. Phase III is planned as a further expansion for 17.2 MW net using two additional power modules similar to Phases I and II.
In addition, a geothermal energy rights concession located 14 kilometers southwest of Guatemala City was awarded to U.S. Geothermal Guatemala S.A., a wholly owned subsidiary of the Company. The concession contains 24,710 acres (100 square kilometers) in the center of the Aqua and Pacaya twin volcano complex.
U.S. Geothermal, Inc. (HTM), closed Friday’s session at $0.3399, up 9.56%, on 165,043 volume with 235 trades. The average volume for the last 60 days is 133,604 and the stock's 52-week low/high is $0.30/$0.71.
Gold Coast Mining Corp. (GDSM)
Orbit Stocks, HotShotStocks, Penny Stock Rumble, JackpotStock Picks, RagingStock Bull, PennyStock MarketBulls, and Bird Gang Stocks reported earlier on Gold Coast Mining Corp. (GDSM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Gold Coast Mining Corp. engages in acquisition opportunities in and out of the mining industry. Many lucrative mining projects sit idle due to lack of capital and/or financing direction. Gold Coast will work to capitalize on these opportunities by securing capital, finance consulting, equipment assistance and other financial assistance to these companies/projects. Gold Coast Mining lists on the OTC Pink Current Information. The Company is based in Boca Raton, Florida.
Currently, Gold Coast Mining is working with Western Sierra Mining (WSRA) to secure and finalize a project (the Gold Star Mine), with financing built in, that the two parties will operate within Gold Coast. The Gold Star Mine, currently owned by WSRA, consists of up to 5 unpatented claims on more than 300 acres near Prescott, Arizona. The claims are near a highway and fully accessible using an unimproved road to the site. Water will be available from wells to be drilled on the property. Local weather allows for a year round production season.
In August, Gold Coast Mining announced an update for the Azurite property (Azurite, New Era, NIWOT Millsite, Little Kid, Wren and Jayhaker). Western Sierra Mining completed an initial road survey; road improvements are needed. The initial focus of the Joint Venture (JV) is improvements leading to the main surface ore body and the opening of some of the existing tunnels. The beginning efforts also include the plant pad cleanup; work on the cabin and notifications to the proper authorities regarding activity at the property.
In September, Gold Coast Mining announced that they executed the Letter of Interest (LOI) to pursue a merger with International Gold Mining Reserve Corp. (IGMR). The Company received an unsolicited LOI from IGMR for a potential merger between the two companies combining properties, resources, as well as management.
Last week, Gold Coast Mining announced that they would complete the process of becoming fully audited as well as get efforts underway for an uplisting to the OTCQB before continuing further merger talks. Both companies are of the opinion that completing audits and pursuing an OTCQB listing first would be in the best interest of Gold Coast Mining shareholders. Gold Coast's first two priorities will be the completion of audits by an S.E.C. qualified auditing firm and the engagement of an S.E.C. qualified law firm. Their primary goal is to complete financial and securities work required in obtaining a potential listing to the OTCQB.
Gold Coast Mining Corp. (GDSM), closed Friday’s session at $0.0017, down 22.73%, on 16,152,942 volume with 35 trades. The average volume for the last 60 days is 7,093,036 and the stock's 52-week low/high is $0.0004/$0.0344.
Strateco Resources, Inc. (SRSIF)
We are reporting on Strateco Resources, Inc. (SRSIF) today, here at the QualityStocks Daily Newsletter.
Incorporated in 2000, Strateco Resources, Inc. engages in the acquisition, development, evaluation, and exploration of mineral properties in Canada. The Company is working to become the first company in Quebec and the first so-called junior company in Canada, in the present cycle, to advance a uranium exploration project involving underground exploration work. Strateco Resources shares trade on the OTC Pink Current Information. The Company is headquartered in Boucherville, Quebec.
Strateco Resources has a portfolio of four wholly owned mining properties. They also own interests in three mining properties located in Quebec. These properties consist of 941 claims covering an area of 49,606 hectares. The Company's activities focus on the exploration and development of the Matoush project located in the Otish Mountains of northern Quebec.
The Matoush project covers 312 km2, at 25 km strike length. The new NI 43-101 resource estimate in January 2012, increased by 50 percent since the last resource estimate in September 2009 at Matoush. Indicated resources are estimated to total 453,000 tonnes grading 0.78 percent U3O8 containing 7.78 million pounds U3O8. Inferred resources are estimated to total 2.04 million tonnes grading 0.43 percent U3O8 containing 19.22 million pounds U3O8. The mineral resources are contained within six zones. These are AM-15, MT-22, MT-34, MT-2, MT-6 and MT-36.
This week, Strateco Resources reported that the Canadian Nuclear Safety Commission (CNSC) granted the Company the license for the underground exploration program at the Matoush uranium project, located in the Otish Mountains of Quebec, approximately 275 km north of Chibougamau and 210 km north of Mistissini. The CNSC attached several conditions to the license, to be met before work starts. This includes the deposit of a $6 million financial security for site rehabilitation.
Additionally, the CNSC is requiring that all the aquatic background data be collected, analyzed, and that the data set be in place. Strateco Resources has already collected and analyzed this data, and will be filing a full report with the CNSC by the end of October 2012. The license is for the maximum allowable period of five years, and is valid from October 16, 2012, until October 31, 2017.
Strateco Resources, Inc. (SRSIF), closed Friday’s session at $0.2855, up 1.96%, on 2,500 volume with 1 trade. The average volume for the last 60 days is 24,240 and the stock's 52-week low/high is $0.184/$0.6115.
Unwired Planet, Inc. (UPIP)
Today we are highlighting Unwired Planet, Inc. (UPIP), here at the QualityStocks Daily Newsletter.
Founded in 1994, Unwired Planet, Inc. owns patents that allow mobile devices to connect to the Internet. The Company's patent portfolio consists of approximately 200 issued U.S. and foreign patents, and approximately 75 pending applications, many that are considered formative to mobile communications, and span smart devices, cloud technologies, and unified messaging. The Company was formerly known as Openwave Systems, Inc. Unwired Planet lists on the NASDAQ Global Select market.
The Company provides Communication Service Providers (CSPs), including wireless and wireline carriers, Internet Service Providers (ISPs), portals, and broadband providers globally, with the software and services they require to build boundary-free, multi-network communications services for their subscribers.
Operators who use Unwired Planet's technology include AT&T, Bell Aliant, Bell Canada, Bell Mobility, Bouygues, Charter, Comcast, Cox Communications, Deutsche Telekom, Du, Etisalat, KDDI, and Qtel. They also include Softbank Mobile, Sprint, Taiwan Mobile, Telefónica Moviles, Telstra, Telus, Time Warner Cable, T-Mobile, Virgin Mobile, Vodacom and Vodafone.
Unwired Planet was the first company to enable operators to deploy mobile Internet browsing. Additionally, they were the first company to create technology that enabled photo messaging. Furthermore, they are the company behind the world's first Wireless Access Protocol (WAP) deployment.
The Company is pursuing a multi-pronged patent monetization strategy. This strategy ranges from direct licensing of their patents, litigation, and collaborating with an Intellectual Property specialist.
This week, Unwired Planet commented on their pending investigation against Apple and Research-in-Motion at the International Trade Commission (ITC). On Thursday, October 11, 2012, Administrative Law Judge (ALJ) Gildea declined to stay the pending investigation despite a joint motion filed by all of the parties. The denial of the joint motion further postponed the ability to appeal what Unwired Planet considers an erroneous claim construction. Unwired Planet has determined that it is in the shareholders' best interest for the Company to terminate the investigation, rather than go ahead with the trial. Instead, their intention is to continue to pursue the matter in their pending case in the Federal District Court of Delaware. This was initially filed in August 2011 in parallel with - and involving the same patents as -the ITC investigation. It provides Unwired Planet with an opportunity to seek a corrected claim construction in the federal court.
Unwired Planet, Inc. (UPIP), closed Friday’s session at $1.42, up 2.90%, on 297,036 volume with 1,082 trades. The average volume for the last 60 days is 360,261 and the stock's 52-week low/high is $1.32/$3.19.
Loans4Less.com, Inc. (LFLS)
The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.11, up 10.00%, on 9,777 volume with 4 trades. The stock’s average daily volume over the past 60 days is 11,718, and its 52-week low/high is $0.01/$0.51.
Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.
Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.
The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.
Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulting on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer
Loans4Less.com, Inc. Company Blog
Loans4Less.com, Inc. News:
Loans4Less.com Provides Preliminary Financial Results for the Third Quarter of 2012
Loans4Less.com, Inc. New Audio Interview With Chairman and CEO Steven M. Hershman
Loans4Less.com, Inc. Announces Engagement of QualityStocks Investor Relations Services.
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.48, up 6.67%, on 5,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 7,934, and its 52-week low/high is $0.43/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Announces New Channel Partnership With Level Seven
GlobalWise Announces Appointment of Kendall D. Gill to Chief Financial Officer Position
MissionIR Features GlobalWise in Exclusive Interview Featuring CEO William Santiago
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.26, up 1.96%, on 52,950 volume with 13 trades. The stock’s average daily volume over the past 60 days is 112,306, and its 52-week low/high is $0.21/$0.78.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corp Discusses Its New Cellular Reprogramming Technology in View of the Recent Award of the Nobel Prize in Physiology or Medicine
International Stem Cell Corp to Participate in Upcoming Investor Conference
International Stem Cell Corp Granted Key Patent for Liver Disease Program
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.206, off by 2.69%, on 97,095 volume with 63 trades. The stock’s average daily volume over the past 60 days is 261,790, and its 52-week low/high is $0.1771/$0.55.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
DUMA - Duma Energy Corp, Zacks Initiating Coverage
Duma Energy Corp. Partners with Hydrocarb to Explore for World Class Reserves in Africa Oil Concession
Duma Energy Receives Approval From Government of Namibia for Exploration License Issued for 5.3 Million-Acre Concession
Not long ago an article in REALTOR Magazine, the official magazine of the National Association of Realtors, reported on the negative effect that the Web was viewed as having on the real estate industry. The article, How the Web Is Ruining Real Estate, detailed the concerns of various real estate professionals that the Web, and social networking in particular, was essentially seducing everyone, including real estate workers, away from “real life” interactions. The feeling expressed was that communication via the Web was fundamentally different than face-to-face dealings, and too much of it could lead to shortened attention spans, self-absorption, and lethargy in personal relationships; things that can be fatal to the successful practice of real estate.
But the article then went on to describe the benefits of an online presence for real estate and other businesses if applied in the correct way, emphasizing that professionals should use the Web to demonstrate their professional expertise by actually showing viewers instead of just telling them.
Although Loans4Less is on the finance side of residential real estate, the article could have used the company as a good example of the Web done right. Loans4Less has learned how to grab and hold the consumer by actively showing them what the company can do, versus just telling them. Instead of being met with an armload of self-promoting text, viewers of Loans4Less sites are immediately presented with easy-to-use services and information, help that is instantly useful. In effect, Loans4Less becomes an expert resource to anyone looking for a mortgage loan. For example, prospects can easily see and/or use any of the following:
• Today’s Rates & Points
• Rate Tracker
• Mortgage Calculator
• Mortgage Pre-Qualifier
• Searchable Glossary
• US Treasury Rates
• Live Market Update
• Guaranteed Closing Costs
• Disclosure of Loan Terms
• Apply Now (Inquiry Form or Application Form)
• The Loan Process
• Client Testimonials
For more information, visit www.Loans4Less.com
The people of Cardium Therapeutics, a San Diego based health sciences and regenerative medicine company, have a good understanding of the complexities, time, and expense involved to bring a new drug to market. It’s a process they’ve been successful in navigating with their two lead products, Generx, a DNA-based angiogenic growth factor therapeutic used to stimulate the growth of blood vessels in heart patients, and Excellagen, a new FDA-cleared highly-refined fibrillar collagen-based topical gel for the management of diabetic ulcers and other wounds. So it hasn’t been lost on the company that there is an explosively growing area of health enhancement with the potential of generating billion dollar products, and with none of the extensive regulatory and other hurdles that are a fundamental part of the pharmaceutical industry.
It’s the world of nutraceuticals, food products designed to provide various health and medical benefits, but which are not subject to the endless testing and regulatory restrictions required for pharmaceutical drugs. Cardium saw the trend early and has its own line of nutraceuticals already well established. MedPodium is a portfolio of premium, science-based, easy to use nutraceuticals, metabolics, and aesthetics designed to promote health and well-being for active professionals. Based on ingredients that have been well characterized scientifically and shown to be capable of promoting healthy lifestyle interests such as enhancing energy, cognition, mood, sleep, weight management, fitness, and aesthetics, the MedPodium line is now a key part of Cardium’s marketing presence. In addition, Cardium has just acquired a privately-held California company that has a popular line of energy and nutritional products, called To Go Brands.
Cardium isn’t alone. For an increasing number of pharmaceutical companies, the advantage of nutraceuticals has been impossible to ignore. With the National Business Journal reporting that the market for dietary supplements is growing at close to 7 percent annually, now generating sales of over $30 billion, and without the costs and headaches of drug development, big-name pharmaceutical companies are taking the industry more seriously than ever before, making smaller companies key takeover targets.
For additional information, visit www.CardiumTHX.com
Progress Software announced it has signed a definitive agreement to sell its Sonic, Savvion, Actional, and DataXtend (DXSI) product lines to Trilogy Enterprises’ investment arm. Trilogy Enterprises is one of the biggest privately held enterprise software companies in the world. The terms of the transaction have not been disclosed.
The agreement with Trilogy Enterprises represents the continued execution of Progress Software’s strategic plan. Progress’ focus on increasing growth, profitability, and shareholder value will continue as the company concentrates on providing the most productive, cost-effective, on-premise cloud-enabled and mobile-enabled platforms for developing, deploying, and maintaining the best business applications in the world. To date, the announced divestitures represent 80 percent of the company’s non-core revenue stream and have served to further enhance Progress’ management team’s focus on current core business. Progress remains committed to the timely divestiture of its remaining non-core product lines.
Subject to customary closing conditions, the transaction is expected to be completed in November 2012. After completion of the transaction, ObjectStore and Orbix (which include Artix and Orbacus products) will be Progress’ only product lines remaining to be divested. The company has, to date, completed its previously announced sale of FuseSource to Red Hat and anticipates that the sale of its Shadow product line to Rocket Software will also be completed soon.
In total, the sales price to date for all divested products and products under agreement to be divested is around $114 million. The combined fiscal 2012 year-to-date revenue of these products is $83 million, representing around 80 percent of Progress’ total non-core revenue stream.
Pacific Crest Securities LLC is serving as the financial advisor for Progress on the transaction, and Wilmer Cutler Pickering Hale and Dorr LLP is serving as the company’s legal counsel.
Progress Software is a worldwide software company focused on simplifying the development, deployment, and management of business application on-premise or on any cloud, any platform, and any device with minimal IT complexity and low total ownership cost.
For more information, visit www.progress.com
American Energy Development, the rapidly emerging oil and gas E&P with some 30k acres of prime hydrocarbon territory in proven basins, both domestically here in Michigan (5,343 acres in the Dansville and White-tail Niagaran Reef prospects), as well as in the UK’s underexplored onshore potential in Windsor (24,700 acres in the Weald Basin), offered financial results for FY12 (ended June 30) today, alongside a 10-K filing.
Chief among the highlights is the transitional Brown 2-12 well on the Dansville prospect, which took AEDC out of mere exploration and into production as it went online in December of last year, pumping some 1,110 bbls ($92.25 average) or more net through full production to mid-year with very little water cut. In addition to closing on the 24.7k-acre Windsor prospect, the company nailed down another big addition to their footprint in Michigan, with the completion of the lease acquisition on the 4k-acre White-tail prospect.
CEO of AEDC, Herold Ribsskog, clearly pleased by the over $89k in revenues generated, underscored the substantial acreage additions also secured during the last year, citing the White-tail prospect in particular as helping to really flesh out the company’s strategic position in the proven Niagaran play. Given that the average Northern Michigan reef is usually a 50 to 400-acre wide, 200 to 7k-foot deep structure within the 12 to 15-mile wide oil bearing reef belt, AEDC’s move to capture a larger strategic footprint in the roughly 2.5M-acre play is sound.
Ribsskog emphasized the established nature of the play, with its 110 or more fields representing reserves in excess of 1M bbls and asserted that the initial seismic survey data obtained from work done prior to the acquisition, offered a clear picture of five distinct reef prospects on new acreage. Ribsskog cited a planned 3D seismic study on the White-tail slated for 2013 and projected 2 to 3 drill sites being initially established as part of a larger program that should turn up the kind of rich, short-lead project stack which could spell some choice near term revenue for AEDC.
The plan for 2013 is to exit the year with multiple sites online and producing in conjunction with upgraded output from the Brown 2-12. Ribsskog assured investors that the company would continue to employ the latest methods for generating empirically validated analysis, like 3D seismic mapping, as AEDC progresses. Ribsskog expressed great confidence in this philosophy, that every project’s economic feasibility is won or lost before the first production drill breaks ground, on the basis of superior information.
Indeed, knowledge is power and one of the driving forces behind AEDC’s success thus far has been this firm commitment to utilizing the latest geological and geophysical technology to minimize shareholder risk. A serious desire for near-term revenue acid testing and a keen eye for building a diverse portfolio have reinforced the rest of the business model quite well. AEDC has a very solid stance from which to pursue yet more incrementally acquired acreage, to a great extent because of the company’s rigorous due diligence attitude and emphasis on proven basins. There is tremendous upside potential in a rapidly emerging company like AEDC and these strong financials for the fiscal year go a long ways towards courting the kind of additional capital expenditure leeway needed to fully realize the obvious potential in Michigan, as well as the vast, less obvious potential in onshore UK hydrocarbons.
Please visit the American Energy Development Corp. website for more information: www.AED-Corp.com
Today's Top 3
Mina Mar Marketing
Wall Street Resources
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Cardium Therapeutics, Inc. (CXM) Announces the Acquisition of To Go Brands
- Consorteum Holdings, Inc. (CSRH) Subsidiary, Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming with the Acquisition of To Go Brands
- GlobalWise Investments, Inc. (GWIV) Announces New Channel Partnership With Level Seven
- GreeneStone Healthcare Corp. (GRST) Implementing 'Build & Buy' Growth Strategy To Capitalize On Huge Opportunity In Behavioral Treatment
- International Stem Cell Corp. (ISCO) Discusses Its New Cellular Reprogramming Technology in View of the Recent Award of the Nobel Prize in Physiology or Medicine
- Loans4Less.com, Inc. (LFLS) New Audio Interview With Mr. Steven M. Hershman, Chairman and CEO via SmallCapVoice
- Skinny Nutritional Corp. (SKNY) to Change the Way You Think About Your Water With the Introduction of Skinny Water pH+
- Teletouch Communications, Inc. (TLLE) Returns as Official Cellular Sponsor for the 10th Anniversary ESPN 2012 Bell Helicopter Armed Forces Bowl
- TNI BioTech Inc. (TNIB) Dr. Henry "Skip" Lenz, Pharm.D, Joins the Company as Quality Control Officer
- VistaGen Therapeutics, Inc. (VSTA) Announces Strategic Financing With Platinum Long Term Growth Fund